Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2018-04-20

Original market date: See footnote 1

1986-12-31

Product name:

TEVA-PREDNISOLONE

DIN:

00700401 Electronic product monograph is not available

Company: 

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada  M1B 2K9

Class: 

Human

Dosage form(s):

Suspension

Route(s) of administration:

Ophthalmic

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

52:08.08   CORTICOSTEROIDS

Anatomical Therapeutic Chemical (ATC): See footnote 4

S01BA04  PREDNISOLONE

Active ingredient group (AIG) number:See footnote 5

0106295001

List of active ingredient(s)
Active ingredient(s) Strength
PREDNISOLONE ACETATE 1 %

Application information

Related information

Contact us

Version 3.9.0
Date modified: